Skip to content

Telemonitoring intensive strategy in early rheumatoid arthritis

Observational study for the evaluation of safety and effectiveness of biologic drugs in patients with inflammatory rheumatic diseases based on a web platform

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13142685
Enrollment
41
Registered
2016-03-17
Start date
2012-01-01
Completion date
Unknown
Last updated
2016-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis Musculoskeletal Diseases Rheumatoid arthritis

Interventions

Participants are randomly allocated to one of two groups. Group 1: Participants have their condition monitored using the intensive telemonitoring strategy, which involves five face-to-face visits (at

Sponsors

Università Politecnica delle Marche
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of rheumatoid arthritis according the 2010 ACR/EULAR criteria for RA 2. Age 18 years and over 3. Disease duration less than 1 year (the disease duration was considered from the onset of the symptoms to baseline that corresponded with the point of diagnosis and with the start of treatment) 4. Clinical Disease Activity Index (CDAI) of 22 or over

Exclusion criteria

Exclusion criteria: 1. Visual limitations were present 2. Hard of hearing and living alone 3. Poor command of the Italian language 4. Suffering from diseases requiring hospitalization such as chronic obstructive pulmonary disease, heart disease, multiple sclerosis, extracorporeal dialysis or chronic infectious disease

Design outcomes

Primary

MeasureTime frame
Disease activity, measured using the clinical disease activity index (CDAI) is measured at baseline and 1 year

Secondary

MeasureTime frame
Comprehensive disease control (CDC), measured using the clinical disease activity index (CDAI) and the Recent-Onset Disability Index (ROAD) at baseline and 1 year

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 13, 2026